PharmAthene's Valortim demonstrates potential for anthrax treatment
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is presenting results of a study demonst...
News-Medical-Net,
Sat Dec 05 01:16:00 PST 2009
• Found on Yahoo! News
New data from PharmAthene's anthrax vaccine program presented
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new data from the Company's anthrax v...
News-Medical-Net,
Fri Dec 04 21:30:40 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News
Former U.K. Health Protection Agency Director Rejoins Emergent BioSolutions to Hea...
ROCKVILLE, Md.----Emergent BioSolutions Inc. is pleased to announce the appointment of Steven Chatfield, Ph.D. as Senior Vice President, Biodefense effective immediately. Dr. Chatfield rejo...
Business Wire via Yahoo! Finance,
Tue Dec 01 03:00:00 PST 2009
• Found on Yahoo! News
PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders ...
ANNAPOLIS, Md., Dec. 4 /PRNewswire-FirstCall/ -- PharmAthene, Inc.
redOrbit,
Fri Dec 04 10:54:21 PST 2009
• Found on Yahoo! News
Risk Factors
Fluids are given, and the skin is kept clean. Medications can help control fever and pain. Antibiotics may be given if other infections develop. Cases are reported to public health official...
ThirdAge,
Fri Dec 04 11:09:25 PST 2009
• Found on Yahoo! News
PharmAthene to present its biological/ chemical weapons countermeasure program dat...
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company will participate in and present data at ...
News-Medical-Net,
Wed Dec 02 03:15:36 PST 2009
• Found on Yahoo! News
Suite Talk: Dec. 3, 2009
Kristin Wells is the newest partner at Patton Boggs, where she
The Politico,
Thu Dec 03 02:13:33 PST 2009
• Found on Yahoo! News
PharmAthene to Present Data for rPA Anthrax Vaccine, Protexia(R) and Valortim(R) a...
PharmAthene, Inc. , a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company will participate in and present data at...
PR Newswire via Yahoo! Finance,
Tue Dec 01 06:25:00 PST 2009
• Found on Yahoo! News
Cleveland BioLabs Inc. (CBLI) COO, Secretary Yakov Kogan sells 6,000 Shares
By insider. COO, Secretary of Cleveland BioLabs Inc. ( CBLI ) Yakov Kogan sells 6,000 shares of CBLI on 12/01/2009 at an average price of $3.75 a share. Read more » »
Guru Focus,
Wed Dec 02 14:30:36 PST 2009
• Found on Yahoo! News
Idaho Tech Simultaneously Seeks CLIA Waiver for FilmArray, FDA OK for Respiratory ...
Idaho Technologies said this week that it has been awarded a $3.3 million grant from the US Defense Threat Agency to help it continue developing its FilmArray PCR platform.
GenomeWeb News,
Wed Dec 02 10:45:32 PST 2009
• Found on Yahoo! News
Idaho Technology Receives $3.3M from DoD
The Defense Threat Reduction Agency on behalf of the U.S. Air Force Assistant Surgeon General, Modernization Directorate (AF/SGR) has awarded Idaho Technology Inc. $3.3 million to advance d...
Medical Device Link,
Wed Dec 02 08:40:52 PST 2009
• Found on Yahoo! News
Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends
Reportlinker.com announces that a new market research report is available in its catalogue:
PR Newswire via Yahoo! Finance,
Wed Dec 02 15:02:00 PST 2009
• Found on Yahoo! News
Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President
PLEASANTON, Calif., Dec. 1 /PRNewswire/ -- The new position of Executive Vice President, Commercial Affairs at Microchip Biotechnologies, Inc.
redOrbit,
Tue Dec 01 17:08:50 PST 2009
• Found on Yahoo! News
Phase I Study Of Preventive HIV Vaccine Shows Improved Immune Responses When The V...
A Phase 1 study of a preventive HIV vaccine testing a novel delivery mechanism known as electroporation - the use of electrical pulses to increase the immune responses elicited by DNA vacci...
Medical News Today,
Tue Dec 01 22:11:01 PST 2009
• Found on Yahoo! News
PharmAthene to Present Data for rPA Anthrax Vaccine, Protexia(R) and Valortim(R) a...
ANNAPOLIS, Md., Dec. 1 /PRNewswire-FirstCall/ -- PharmAthene, Inc.
redOrbit,
Tue Dec 01 08:12:19 PST 2009
• Found on Yahoo! News
Top 10 innovations of 2009
The ten most exciting tools to hit the life sciences this year
The Scientist,
Tue Dec 01 09:37:10 PST 2009
• Found on Yahoo! News
Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President
The new position of Executive Vice President, Commercial Affairs at Microchip Biotechnologies, Inc. has been taken up by Howard Goldstein, a biotech lab systems executive with more than 30 ...
PR Newswire via Yahoo! Finance,
Tue Dec 01 12:57:00 PST 2009
• Found on Yahoo! News
Reader views (35)
Those people with families who are worried , ask your local police where they stand on enforcing a manditory vaccination , ask nicley and remind them its there job to protect the people not...
Evening Standard,
Sun Nov 29 20:45:04 PST 2009
• Found on Yahoo! News
Phase I Study of Preventive HIV Vaccine Shows Improved Immune Responses When the V...
NEW YORK & SAN DIEGO----A Phase 1 study of a preventive HIV vaccine testing a novel delivery mechanism known as electroporation
Business Wire via Yahoo! Finance,
Mon Nov 30 05:00:00 PST 2009
• Found on Yahoo! News